Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 4,697 | 5,756 | 6,708 | 10,129 | 7,230 |
| Operating Income | -4,697 | -5,756 | -6,708 | -10,129 | -7,230 |
| Other Income | -861 | 515 | 1,176 | 4,021 | 2,148 |
| Pre-tax Income | -5,558 | -5,240 | -5,532 | -6,108 | -5,082 |
| Net Income Continuous | -5,558 | -5,240 | -5,532 | -6,108 | -5,082 |
| Net Income | $-5,558 | $-5,240 | $-5,532 | $-6,108 | $-5,082 |
| EPS Basic Total Ops | -0.09 | -0.08 | -0.09 | -0.10 | -0.08 |
| EPS Basic Continuous Ops | -0.09 | -0.08 | -0.09 | -0.10 | -0.08 |
| EPS Diluted Total Ops | -0.09 | -0.08 | -0.09 | -0.10 | -0.08 |
| EPS Diluted Continuous Ops | -0.09 | -0.08 | -0.09 | -0.10 | -0.08 |
| EBITDA(a) | $-4,653 | $-5,713 | $-6,662 | $-10,089 | $-7,188 |